检索结果 - Beth Eaby‐Sandy

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer

    Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer 由 Chia‐Yu Chu, Jennifer Choi, Beth Eaby‐Sandy, Corey J. Langer, Mario E. Lacouture

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

    Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities 由 Mario E. Lacouture, Milan J. Anadkat, René‐Jean Bensadoun, Jane Bryce, Alexandre Chan, Joel B. Epstein, Beth Eaby‐Sandy, Barbara A. Murphy

    出版 2011
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer

    <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer 由 Kartik Konduri, Jean‐Nicolas Gallant, Young Kwang Chae, Francis J. Giles, Barbara J. Gitlitz, Kyle Gowen, Eiki Ichihara, Taofeek K. Owonikoko, Vijay Peddareddigari, Suresh S. Ramalingam, Satyanarayan K. Reddy, Beth Eaby‐Sandy, Tiziana Vavalà, Andrew R. Whiteley, Heidi Chen, Yingjun Yan, Jonathan H. Sheehan, Jens Meiler, Deborah Morosini, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Christine M. Lovly

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: